Premium Nahrungsergänzungsmittel | artgerecht

Aerobiosis Status – Definition and Clinical Relevance

The aerobiosis status describes whether a microorganism grows in the presence or absence of oxygen. It is essential for the diagnosis and treatment of bacterial infections.

Regular tips about health Regular tips about health

Things worth knowing about "Aerobiosis Status"

The aerobiosis status describes whether a microorganism grows in the presence or absence of oxygen. It is essential for the diagnosis and treatment of bacterial infections.

What is the Aerobiosis Status?

The aerobiosis status is a microbiological term that describes the relationship between a microorganism – particularly a bacterium – and molecular oxygen (O₂). It indicates whether a pathogen requires oxygen for growth and metabolism, merely tolerates it, or whether oxygen is actually toxic to it. This characteristic is fundamental to the classification of bacteria and has direct implications for the diagnosis and treatment of bacterial infections.

Classification by Aerobiosis Status

Microorganisms are grouped according to their oxygen requirements as follows:

Obligate aerobic bacteria: These organisms strictly require oxygen for their metabolism and can only grow and survive in the presence of O₂. Examples include Mycobacterium tuberculosis and Pseudomonas aeruginosa.
Obligate anaerobic bacteria: These microorganisms cannot tolerate oxygen. Oxygen is toxic to them because they lack the enzymes necessary to neutralize reactive oxygen species. They are commonly found in deep wounds, abscesses, or the gastrointestinal tract. Examples include Clostridium difficile and Bacteroides fragilis.
Facultatively anaerobic bacteria: These organisms prefer oxygen but can also grow without it by switching to anaerobic metabolic pathways such as fermentation. Examples include Escherichia coli and Staphylococcus aureus.
Microaerophilic bacteria: These organisms require oxygen but at significantly lower concentrations than found in the normal atmosphere (approximately 5% O₂ instead of 21%). Examples include Helicobacter pylori and Campylobacter spp.
Aerotolerant anaerobes: These bacteria live anaerobically but are not killed by oxygen. They can survive in its presence without benefiting from it. Examples include Lactobacillus spp.

Clinical Significance

The aerobiosis status is of central importance in clinical microbiology. It significantly influences:

Culture and cultivation of pathogens: In the laboratory, samples must be incubated under the correct atmospheric conditions. Anaerobic organisms require specialized anaerobic culture vessels or chambers that exclude oxygen.
Infection localization: The aerobiosis status often provides clues about the site of an infection. Anaerobic infections typically occur in oxygen-poor tissues such as deep wounds, necrotic tissue, abscesses, or the gastrointestinal tract.
Antibiotic selection: Many antibiotics act selectively against aerobic or anaerobic organisms. Knowledge of the aerobiosis status of the causative pathogen is therefore critical for targeted and effective antibiotic therapy. Metronidazole, for example, is primarily effective against anaerobic bacteria.

Diagnosis and Determination of Aerobiosis Status

The aerobiosis status is determined in the microbiological laboratory. A patient sample – such as a wound swab, blood, or cerebrospinal fluid – is cultured on various culture media under both aerobic and anaerobic conditions. The growth behavior of the pathogen on the respective media allows for its classification into the appropriate group. Biochemical tests and molecular biological methods such as PCR can be used additionally to identify the organism.

Relevance for Treatment

When a bacterial infection is clinically suspected – particularly in cases of abscesses, wound infections, or intra-abdominal infections – knowledge of the aerobiosis status of the causative pathogen is critical for treatment success. An empirical antibiotic therapy covering both aerobic and anaerobic organisms (so-called combination therapy) is frequently initiated until the specific pathogen and its aerobiosis status have been identified by laboratory diagnostics. Once culture results are available, the therapy can then be adjusted accordingly.

References

Murray, P.R., Rosenthal, K.S., Pfaller, M.A. - Medical Microbiology, 9th Edition, Elsevier (2020).
World Health Organization (WHO) - Antimicrobial Resistance: Global Report on Surveillance, Geneva (2014), available at: www.who.int.
Baron, S. (Ed.) - Medical Microbiology, 4th Edition, University of Texas Medical Branch at Galveston (1996), available via NCBI Bookshelf.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.